Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $835.38 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $162.15 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $94.50 | 5 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $83.78 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $80.57 | 5 | $0 (2024) |
| Alkermes, Inc. | $61.41 | 3 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $60.93 | 4 | $0 (2024) |
| Amgen Inc. | $51.77 | 3 | $0 (2024) |
| Corium, LLC | $41.13 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $37.46 | 2 | $0 (2024) |
| Novo Nordisk Inc | $36.57 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $567.45 | 32 | Otsuka America Pharmaceutical, Inc. ($94.50) |
| 2023 | $213.24 | 9 | ABBVIE INC. ($137.36) |
| 2022 | $54.69 | 3 | Amgen Inc. ($20.60) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.77 | General |
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Neuropsychiatry | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Central Nervous System | ||||||
| 11/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: CNS | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/02/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: CNS | ||||||
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Central Nervous System | ||||||
| 09/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Neuropsychiatry | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Neuropsychiatry | ||||||
| 08/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 696 | 923 | $108,586 | $22,249 |
| 2022 | 14 | 632 | 1,116 | $163,123 | $32,667 |
| 2021 | 4 | 112 | 319 | $57,834 | $13,648 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 209 | $45,604 | $12,212 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 71 | $10,418 | $3,334 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 182 | $6,734 | $1,488 | 22.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 91 | 114 | $12,882 | $1,163 | 9.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 15 | $990.00 | $970.20 | 98.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 72 | 76 | $10,716 | $960.38 | 9.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 91 | 113 | $8,701 | $840.90 | 9.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 17 | $1,122 | $485.69 | 43.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 32 | $4,192 | $304.64 | 7.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 68 | 71 | $4,402 | $220.81 | 5.0% |
| 86738 | Analysis for antibody to mycoplasma (bacteria) | Office | 2023 | 11 | 12 | $1,692 | $155.76 | 9.2% |
| 83721 | Ldl cholesterol level | Office | 2023 | 11 | 11 | $1,133 | $113.19 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 162 | $35,883 | $10,534 | 29.4% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 45 | 225 | $50,625 | $8,442 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 168 | $26,270 | $7,426 | 28.3% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Office | 2022 | 18 | 82 | $9,512 | $1,346 | 14.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 84 | 107 | $12,091 | $1,083 | 9.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $990.00 | $970.20 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $1,452 | $602.36 | 41.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 63 | 71 | $5,467 | $529.93 | 9.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 39 | 39 | $5,499 | $512.66 | 9.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 92 | 139 | $5,143 | $402.07 | 7.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 21 | 33 | $4,323 | $314.89 | 7.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 13 | 15 | $2,610 | $231.97 | 8.9% |
| 83721 | Ldl cholesterol level | Office | 2022 | 21 | 22 | $2,266 | $226.58 | 10.0% |
About Ann Mojeiko, NP
Ann Mojeiko, NP is a Nurse Practitioner healthcare provider based in Clinton, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2021. The National Provider Identifier (NPI) number assigned to this provider is 1801463245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ann Mojeiko, NP has received a total of $835.38 in payments from pharmaceutical and medical device companies, with $567.45 received in 2024. These payments were reported across 44 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($835.38).
As a Medicare-enrolled provider, Mojeiko has provided services to 1,440 Medicare beneficiaries, totaling 2,358 services with total Medicare billing of $68,563. Data is available for 3 years (2021–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Clinton, IA
- Active Since 06/04/2021
- Last Updated 06/04/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801463245
Products in Payments
- QULIPTA (Drug) $103.19
- REXULTI (Drug) $89.96
- INGREZZA (Drug) $80.57
- Austedo XR (Drug) $66.03
- CAPLYTA (Drug) $60.93
- ARISTADA (Drug) $41.26
- Azstarys (Drug) $41.13
- ABILIFY MAINTENA (Drug) $37.77
- Rybelsus (Drug) $36.57
- UBRELVY (Drug) $34.17
- VRAYLAR (Drug) $24.79
- Omnipod (Device) $22.34
- EVENITY (Biological) $20.60
- GARDASIL 9 (Biological) $20.57
- VIVITROL (Drug) $20.15
- COBENFY (Drug) $18.69
- PERSERIS (Drug) $18.53
- UZEDY (Drug) $17.75
- Repatha (Biological) $17.04
- SUBLOCADE (Drug) $16.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Clinton
Frankie Britt, Fnp, FNP
Nurse Practitioner — Payments: $5,028
Laurie Boyd, Np, NP
Nurse Practitioner — Payments: $1,795
Kimberly Campbell, Arnp, ARNP
Nurse Practitioner — Payments: $751.69
Sheryl Deguzman-Buenaventura, Np, NP
Nurse Practitioner — Payments: $652.01
Veronica Hunter, Fnp-C, FNP-C
Nurse Practitioner — Payments: $581.03
Allie Turpin, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $480.16